Literature DB >> 17679060

Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease.

Daniel S Berman1, Xingping Kang, Piotr J Slomka, James Gerlach, Ling de Yang, Sean W Hayes, John D Friedman, Louise E J Thomson, Guido Germano.   

Abstract

BACKGROUND: There have been limited data regarding the value of gated single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) for the detection of left main coronary artery disease (CAD). METHODS AND
RESULTS: We studied 101 patients with angiographic left main CAD (> or = 50% stenosis) and no prior myocardial infarction or coronary revascularization who underwent gated exercise or adenosine stress technetium 99m sestamibi SPECT MPI. By perfusion assessment alone, high-risk disease with moderate to severe defects (> 10% myocardium at stress) was identified in only 56% of patients visually and 59% quantitatively. Absence of significant perfusion defect (> or = 5% myocardium) was seen in 13% of patients visually and 15% quantitatively. However, by combining visual perfusion data and nonperfusion variables, especially transient ischemic dilation, 83% of patients were identified as high risk.
CONCLUSIONS: The findings of this study demonstrate that assessment of perfusion data alone by visual or quantitative SPECT MPI analysis underestimates the magnitude of left main CAD. The combination of perfusion and nonperfusion abnormalities on gated MPI identifies high risk in most patients with left main CAD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17679060     DOI: 10.1016/j.nuclcard.2007.05.008

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  36 in total

1.  Automated quantification of myocardial perfusion SPECT using simplified normal limits.

Authors:  Piotr J Slomka; Hidetaka Nishina; Daniel S Berman; Cigdem Akincioglu; Aiden Abidov; John D Friedman; Sean W Hayes; Guido Germano
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

2.  Combined supine and prone quantitative myocardial perfusion SPECT: method development and clinical validation in patients with no known coronary artery disease.

Authors:  Hidetaka Nishina; Piotr J Slomka; Aiden Abidov; Shunichi Yoda; Cigdem Akincioglu; Xingping Kang; Ishac Cohen; Sean W Hayes; John D Friedman; Guido Germano; Daniel S Berman
Journal:  J Nucl Med       Date:  2006-01       Impact factor: 10.057

3.  Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5-9 years. I. Arterographic correlations.

Authors:  A V Bruschke; W L Proudfit; F M Sones
Journal:  Circulation       Date:  1973-06       Impact factor: 29.690

4.  Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia.

Authors:  R Hachamovitch; D S Berman; H Kiat; I Cohen; H Lewin; A Amanullah; X Kang; J Friedman; G A Diamond
Journal:  Am J Cardiol       Date:  1997-08-15       Impact factor: 2.778

5.  Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study.

Authors:  Aiden Abidov; Rory Hachamovitch; Sean W Hayes; Chee Keong Ng; Ishac Cohen; John D Friedman; Guido Germano; Daniel S Berman
Journal:  Circulation       Date:  2003-06-09       Impact factor: 29.690

6.  Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography.

Authors:  D S Berman; R Hachamovitch; H Kiat; I Cohen; J A Cabico; F P Wang; J D Friedman; G Germano; K Van Train; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1995-09       Impact factor: 24.094

7.  Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography.

Authors:  Aiden Abidov; Rory Hachamovitch; Alan Rozanski; Sean W Hayes; Marcia M Santos; Maria G Sciammarella; Ishac Cohen; James Gerlach; John D Friedman; Guido Germano; Daniel S Berman
Journal:  J Am Coll Cardiol       Date:  2004-09-01       Impact factor: 24.094

8.  Exercise thallium-201 myocardial imaging in left main coronary artery disease: sensitive but not specific.

Authors:  T Rehn; L S Griffith; S C Achuff; I K Bailey; B H Bulkley; R Burow; B Pitt; L C Becker
Journal:  Am J Cardiol       Date:  1981-08       Impact factor: 2.778

9.  False-negative myocardial scintigraphy in balanced three-vessel disease, revealed by coronary pressure measurement.

Authors:  Wilbert H Aarnoudse; Kees-Joost B M Botman; Nico H J Pijls
Journal:  Int J Cardiovasc Intervent       Date:  2003

10.  Myocardial revascularization in patients with multivessel coronary artery disease and minimal angina pectoris.

Authors:  J Wynne; L H Cohn; J J Collins; P F Cohn
Journal:  Circulation       Date:  1978-09       Impact factor: 29.690

View more
  121 in total

1.  Prospective evaluation of a new protocol for the provisional use of perfusion imaging with exercise stress testing.

Authors:  W Lane Duvall; John A Savino; Elliot J Levine; Luke K Hermann; Lori B Croft; Milena J Henzlova
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-11-04       Impact factor: 9.236

2.  Diagnostic performance of combined noninvasive coronary angiography and myocardial perfusion imaging using 320 row detector computed tomography: design and implementation of the CORE320 multicenter, multinational diagnostic study.

Authors:  Andrea L Vavere; Gregory G Simon; Richard T George; Carlos E Rochitte; Andrew E Arai; Julie M Miller; Marcello Di Carli; Armin Arbab-Zadeh; Armin A Zadeh; Marc Dewey; Hiroyuki Niinuma; Roger Laham; Frank J Rybicki; Joanne D Schuijf; Narinder Paul; John Hoe; Sachio Kuribyashi; Hajime Sakuma; Cesar Nomura; Tan Swee Yaw; Klaus F Kofoed; Kunihiro Yoshioka; Melvin E Clouse; Jeffrey Brinker; Christopher Cox; Joao A C Lima
Journal:  J Cardiovasc Comput Tomogr       Date:  2011-11-12

3.  Use of high-risk features from exercise treadmill testing to identify obstructive left main disease with normal myocardial perfusion imaging.

Authors:  Marcio Sommer Bittencourt; Sharmila Dorbala; Michael Steigner; Frank Rybicki; Marcelo Di Carli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2012-08       Impact factor: 5.952

4.  Does the location of perfusion defects matter? An old question with a new answer.

Authors:  Mouaz H Al-Mallah; Waqas Qureshi
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

Review 5.  Stress CT perfusion: coupling coronary anatomy with physiology.

Authors:  Edward A Hulten; Marcio Sommer Bittencourt; Brian Ghoshhajra; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

6.  Novel and simple carbon-11-labeled ammonium salts as PET agents for myocardial perfusion imaging.

Authors:  Ohad Ilovich; Hana Billauer; Sharon Dotan; Nanette M T Freedman; Moshe Bocher; Eyal Mishani
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

Review 7.  Value of coronary CTA in patients with known or suspected CAD and non-diagnostic initial myocardial perfusion testing: current evidence and clinical considerations.

Authors:  Aiden Abidov; Gilbert L Raff
Journal:  J Nucl Cardiol       Date:  2010-12       Impact factor: 5.952

Review 8.  Non-invasive imaging in coronary artery disease including anatomical and functional evaluation of ischaemia and viability assessment.

Authors:  M Pakkal; V Raj; G P McCann
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 9.  Assessing clinical impact of myocardial perfusion studies: ischemia or other prognostic indicators?

Authors:  Todd D Miller; John Wells Askew; Joerg Herrmann
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

Review 10.  Myocardial ischemia is a key factor in the management of stable coronary artery disease.

Authors:  Kohichiro Iwasaki
Journal:  World J Cardiol       Date:  2014-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.